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ABSTRACT 
Endothelin receptor A (Ednra) signaling pathway is involved in many 
pathological and physiological conditions, yet the pathway and the genes regulated by 
the pathway remain largely unknown. Ednra mutant murine embryos are known to 
present with cardiovascular defects including patent ductus arteriosus, coarctation of the 
aortic arch, ventricular septal defects indicating issues with remodeling of the 
pharyngeal arch arteries, and improper development of the cardiac outflow tract among 
others. To elucidate the expression of specific genes involved during cardiovascular 
development in these mutants we first generated Ednra-/- murine embryos and 
performed whole mount in situ hybridization at embryonic day E9.5 and discovered 
altered gene activity that could explain the cardiovascular defects seen in these mutants. 
We also looked into the problem of cardiac neural crest cell migration using 
immunohistochemistry to analyze the Rho family of GTPases. We discovered that in the 
cardiac outflow tract neural crest cells, Endothelin receptor A signaling involves Cdc42 
activity. 
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NOMENCLATURE 
ANP Atrial natriuretic peptide 
BMP Bone morphogenic protein 
CCR1 Chemokine Receptor 1 
CNCC Cardiac neural crest cells 
COFT Cardiac outflow tract 
E Embryonic day 
ECE1 Endothelin Converting Enzyme 1 
ECE2 Endothelin Converting Enzyme 2 
Edn1 Endothelin 1 
Ednra Endothelin A receptor, Endothelin receptor A  
FGF Fibroblast growth factor 
NCC Neural crest cells 
Nppa Natriuiretic peptide A 
PAA Pharyngeal arch arteries 
PCR Polymerase chain reaction 
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11. INTRODUCTION AND LITERATURE REVIEW
Congenital cardiovascular defects affect one in 110 births; such a high 
prevalence of defects in humans is a driving force in understanding the genes and 
pathways involved during normal heart development. The heart is the first functional 
organ to form in a developing embryo. Cardiovascular development is a long and 
complex process beginning before the neural tube is formed and finishing after birth 
with the closure of the ductus arteriosus (Carlson 2013). The development of the heart 
begins with the formation of two endocardial tubes within the anterior mesoderm that 
merge to form the primitive heart tube (Carlson 2013). Rapid looping and differentiation 
of the tubular heart into the truncus arteriosus, bulbus cordis, primitive ventricle, 
primitive atrium and sinus venosus occurs in early development (Carlson 2013). The 
truncus arteriosus will divide and form the pulmonary artery and aorta; the bulbus cordis 
will develop into the right ventricle; the primitive ventricle will form the left ventricle; 
the primitive atrium forms the anterior portion of the left and right atrium; the sinus 
venosus contributes to the posterior part of the right atrium (Carlson 2013). The basic 
cellular unit of the heart is the cardiomyocyte, with unique subtypes categorized by 
location and specialized function. While much is known about the myocardium of the 
heart, there is relatively little understood about the factors involved in maturation of 
these cell lineages.  
One cell population involved in the development of the cardiovascular region is a 
group known as the neural crest cells. Neural crest cells are multipotent cells that 
delaminate from the ectoderm layer following the transition from epithelial to 
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mesenchymal cell types during early embryogenesis. A subpopulation of these cells 
become what is referred to as cardiac neural crest cells which gain the ability to migrate 
along the dorsolateral pathway to the circumpharyngeal region (reviewed by Keyte and 
Hutson 2012). 
Cardiac neural crest cells (CNCC) continue migrating into the pharyngeal arches, 
with particular localization in the third, fourth, and sixth pharyngeal arches as well as 
into the cardiac outflow tract (Snider et al. 2007; reviewed by Keyte and Hutson 2012). 
The cardiac outflow tract temporarily connects the future primitive ventricles with the 
aortic sac during development of the heart and is where a portion of the cardiac neural 
crest cells migrate under normal conditions. At murine embryonic day (E) 9.5 the 
cardiac neural crest cells are migrating into the outflow tract to participate in its 
septation. CNCCs contribute to the developing heart including forming portions of the 
septum and contributing muscle and connective tissue to the walls of large arteries 
(Hutson and Kirby 2003). The aortic arch, ductus arteriosus, and proximal segments of 
the carotid arteries comprise a significant portion of crest cells as the CNCC associated 
with the pharyngeal arch arteries contribute to the smooth muscle layer surrounding 
these vessels (Snider et al. 2007). Cells that migrated within the pharyngeal arches will 
populate the region and form the pharyngeal arch arteries (PAA). These cells that form 
the PAA will also participate in the remodeling of these structures. There are five paired 
arch arteries in mammalian development and they are numbered I to VI. The fifth is 
believed to be rudimentary, and the first and second PAA mostly disappear during the 
later stages of embryogenesis with both contributing to other structures (Carlson 2013). 
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The first will appear in part of the maxillary arteries on both the right and left sides, and 
the second contributes to the hyoid and stapedial arteries on both sides (Carlson 2013). 
The PAA remodel with the remodeling of the heart tube as the outflow tract divides into 
aortic and pulmonary components (Carlson 2013). The third PAA undergoes remodeling 
and forms the carotid artery system in the developing embryo (Carlson 2013). The fourth 
and sixth PAAs both undergo asymmetrical remodeling with the development of the 
heart (Carlson 2013). The left fourth is incorporated into the arch of the aorta, and the 
right fourth the right subclavian artery. The sixth PAA arises as a capillary plexus and is 
more appropriately called the pulmonary arch, as it is incorporated into the right and left 
pulmonary arteries, with the right sixth degenerating and the left sixth forming the 
ductus arteriosus.  (Carlson 2013).   
de la Cruz and colleagues showed evidence, as early as 1977, that a second 
source of myocardium was involved in the complex formation of the heart and that the 
heart tube formation occurred prior to the addition of the outflow tract (de la Cruz et al. 
1977). The first heart field, primitive anterior mesoderm, contributes to the left ventricle, 
AV canal, and atria and specifically refers to the mesodermal cells that differentiate to 
form the primordial heart tube. The second or anterior heart field refers to the 
progenitors added to this heart tube and contribute to the remainder of the heart, 
including a portion of the right atrium and the base of the outflow tract. While de la Cruz 
and colleagues were the first to express the thought that there were regions in the heart 
formed by a second source of myocardium, it was not until 2001 when three different 
groups molecularly described this population of cells. Using a fibroblast growth factor 
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(FGF) 10-nlacZ reporter mouse, Kelly and colleagues demonstrated a model that showed 
expression in the right ventricle and outflow tract myocardium at E9.5, and with labeling 
techniques, were able to show that this myocardium was added from the pharyngeal arch 
core and the splanchnic mesoderm (Kelly et al. 2001). Mjaatvedt et al., and Waldo et al. 
identified sources of the outflow tract myocardium using the embryonic chick with both 
using cell labeling to determine the origin of these cells (Mjaatvedt et al. 2001, Waldo et 
al. 2001). These three groups identified and referred to a subpopulation of the secondary 
heart field based upon their findings, leaving us with slightly varied terminology when 
referring to this population of cells. The region defined by the FGF 10-lacZ expression is 
deemed the anterior heart field and consists of the right ventricle and outflow tract 
progenitors (Kelly et al, 2001). While the secondary heart field identified by Waldo et 
al., refers to the mesoderm that gives rise to the distal outflow tract, specifically the 
arterial pole (Waldo et al, 2001). The cardiac neural crest cells play a crucial role in this 
stage of development as they are needed to induce the migration of these secondary heart 
field myocytes. 
One of the signaling pathways important in cardiac development, including the 
migration of the CNCC and the rearrangement of the PAAs, involves the function of 
Endothelin receptor type A (Ednra). There are two Endothelin receptors: Endothelin A 
receptor and Endothelin B receptor and three associated ligands: Endothelin 1, 2, and 3. 
Physiological effects of Endothelin B receptor typically oppose the actions of Endothelin 
A receptor. Activation of Endothelin B receptor occurs normally in conjunction with 
Endothelin 3. The activation of Endothelin B receptor results in vasodilation, naturiesis 
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and diuresis as effects to lower blood pressure. Ednrb and Edn3 mutations are associated 
with Hirschsprung's disease in humans and piebald lethal in horses and inactivation 
causes similar defects in mice as enteric nerves are not properly formed. The Endothelin 
A receptor (Ednra) on the other hand is an important signaling molecule known to 
produce vasoconstrictive effects when it is activated by the ligand Endothelin-1 (Edn1) 
under normal physiological conditions. Ednra upregulates the production of Edn1 and is 
the favored receptor for Edn1 and has almost no affinity for Edn2 or 3 (Kedzierski and 
Yanagisawa 2001). The Endothelin ligand undergoes a process before becoming 
biologically active. After the furin-like  endopeptidases cleave prepro Edn1 into pro 
Edn1 (formerly big End1), the Endothelin-converting enzyme (ECE) 1 or 2 cleaves pro 
Edn1. This cleaving process results in the bioactive 21-amino acid peptide known as 
Edn1 (Kedzierski and Yanagisawa 2001). Both Edn1 and Ednra mutants have been 
shown to present with similar craniofacial and cardiovascular defects (Clouthier et al., 
1998; Ruest et al., 2004; Ruest and Clouthier, 2009; Kurihara et al. 2009). Inactivation 
of the Endothelin converting enzyme genes ECE1 and ECE2 confirms that the 
Endothelin receptor A / Endothelin 1 pathway has a different function than Endothelin 
receptor B /Endothelin 3 pathway during development (Yanagisawa et al. 2000). 
Ednra is a seven pass transmembrane G protein-coupled receptor. Ednra 
signaling is involved in several pathological and physiological pathways including 
vasoconstrictive effects on smooth muscle, patterning, and vessel formation. Ednra is 
present in the vessels of the kidney, in both the medullar and cortical regions, playing a 
role in the renin/angiotensin system (Wendel 2006; Neuhofer and Pittrow 2006). Ednra 
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is associated with aggressive cancers, mainly in bone-localized metastases, and 
disruptions in the Ednra pathway are linked to inflammatory diseases, such as pulmonary 
hypertension, as well as other diseases, such as congestive heart failure, cardiac 
hypertrophy, chronic kidney disease, systemic hypertension, tissue fibrosis and possibly 
preeclampsia (Zhang, et al. 2013; Barton and Yanagisawa, 2008; George and Granger 
2011). Endothelin is also involved in the inflammatory process and may play a role in 
disease states such as periodontitis (Fujioka, Nakamura, Yoshino et al. 2003). Ednra 
expression is regulated by progesterone, which could potentially explain the association 
between Ednra and aggressive feminine cancers, such as metastatic breast cancer (Zhang 
et al. 2013). While the Ednra pathway is known to have implications in pathological and 
physiological conditions alike, there is much to investigate before this signaling pathway 
is fully understood (Barton and Yanagisawa, 2008). 
Ednra is expressed in cranial and cardiac neural crest-derived mesenchymal cells 
and consequently has an effect on the development of the craniofacial and 
cardiovascular regions during embryogenesis (Clouthier et al., 1998; Ruest et al., 2004; 
Ruest and Clouthier, 2009). Mice that are lacking the Endothelin receptor type A suffer 
from severe craniofacial and cardiovascular defects, causing neonatal lethality (Clouthier 
et al., 1998; Ruest et al., 2004). Inactivation of Ednra signaling results in the homeotic 
transformation of the mandible into upper jaw-like structures (Ruest and Clouthier, 
2009; Ruest et al. 2004). The transformation is caused by the disrupted expression of the 
homeotic genes Dlx5 and Dlx6 in the mandibular pharyngeal arch and inactivation of 
these two genes causes similar craniofacial defects (Ruest and Clouthier, 2009; Ruest et 
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al. 2004). Conditional inactivation or the use of a specific receptor antagonist revealed 
that Ednra is one of the earliest mechanisms involved in neural crest cell patterning 
around E9.0 in the mandibular arch and a similar timing is believed to occur for the 
posterior pharyngeal arches while these cells are migrating toward the arches and cardiac 
outflow tract (Ruest and Clouthier 2009). 
Ednra-/- mice present with defects similar to the cardiovascular defects observed 
in patients with DiGeorge syndrome. However, the evidence from the analysis 
comparing the DiGeorge's candidate gene, Tbx1, and Ece1 supports the theory that the 
Endothelin pathway works independently from the Tbx1/Fgf8 pathway in neural crest-
derived structures (Morishima et al., 2003). 
 The cardiovascular defects seen in Ednra mutant embryos commonly include 
persistent patent ductus arteriosus, coarctation of the aorta, ventricular septal defects 
and, more rarely, missing or improper attachment of the right subclavian artery, 
persistent truncus arteriosus and double outlet right ventricle. Potential causes that would 
explain the cardiovascular defects include migration problems, abnormal apoptosis or 
proliferation, or problems with patterning. We know the defects occurring in Ednra 
mutant embryos affect the remodeling of the pharyngeal arch arteries and the migration 
of the CNCC in the cardiac outflow tract (COFT), which occurs at an early stage of 
development. It has been previously noted that there appears to be inappropriate 
migration of the cardiac neural crest cells in the outflow tract of Ednra mutant embryos 
(Abe et al. 2007). We introduced Wnt1-Cre and Rosa26R (R26R) into the Ednra-/- line 
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to determine the fate of the CNCC in the Ednra-/- embryos during cardiovascular 
development.  
 The result of the fate mapping analysis showed that at E9.5 the CNCC populated 
normally the caudal pharyngeal arches and arteries in the mutant embryos (Figure 1). 
Their migration did, however, appear to halt prematurely after entering the truncus 
portion of the outflow tract. Analysis of E10.5 embryos revealed that the phenotype 
persisted in the COFT with cardiac neural crest cells located in the proximal portion of 
the truncus (Figure 2). Fate mapping analysis of E18.5 Ednra-/- embryos revealed that 
cardiac neural crest cells are found in the great arteries but not in the superior portion of 
the heart (Figure 3). The malformed vascular structures include coarctation of the aorta 
and patent ductus arteriosus and these structures, though malformed, contain CNCC 
(Figure 3). 
 In order to verify the defects are not caused by abnormal apoptosis or 
proliferation, the TUNEL assay and Brdu labeling was performed to identify apoptotic 
and proliferating cells. Analysis of the E9.5 embryos did not reveal any significant 
differences in the proliferation (p=0.8597) or survival (p=0.7111) percentages of CNCC 
in the COFT between the wild type and mutant mice (Figure 4). However, significantly 
fewer CNCC were visible between the endomysium and myomysium in each section 
(p<0.0001) (Fig. 4A). We reanalyzed the apoptotic death at E10.5 since only the 
apoptosis rate differences were observed in the mandibular arch at that age. No 
significant differences (p=0.8325) were observed between the wild type and mutant 
embryos (Fig. 4 and data not shown). We concluded that neither apoptosis nor a 
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reduction in cell proliferation was the cause of the apparent migratory arrest of the 
CNCC in the COFT.  
 We hypothesized that the premature arrest of CNCC migration in the outflow 
tract was likely due to abnormal expression of specific genes that necessary for their 
migration. In this study, we examined the anatomical expression of genes in an attempt 
to elucidate the Endothelin signaling pathway and hypothesized that Ednra mutants 
would display altered gene expression when compared to the wildtype embryos. We 
looked at E9.5 Ednra knockout mice when the migratory phenotype appears.  
Also, we examined whether the distribution of Rho family of small GTPases was altered 
in the mutant embryos. These factors, including Rho, Rac and Cdc42, are known for 
their role in cell migration and possibly in the migration of CNCC in the outflow tract. 
Our results should help to elucidate the role of Endothelin receptor A signaling during 
cardiovascular development. 
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2. PROBLEM 
 Congenital cardiovascular defects affect one in 110 human births. This high rate 
of defects is a driving force for research in this area, especially involving the etiology of 
these defects. Elucidating the role of crucial pathways during normal heart development 
is important in understanding how this process works so we can one day help prevent 
some of these congenital defects. Even though Ednra is known to play a role in many 
important physiological and pathological pathways, there is much to learn about this 
crucial signaling pathway during cardiovascular development.  
 The cardiovascular defects seen in Ednra mutant embryos are caused by 
disrupted gene expression and mainly include persistent ductus arteriosus, coarctation of 
the aorta and ventricular septal defects, among others. Understanding the changes in 
gene expression in Ednra mutant embryos will aid in understanding the mechanisms 
involved during the normal and abnormal cardiac development process and may 
eventually lead to the development of preventative treatments in utero for similar 
congenital cardiovascular defects. 
 We know from our fate mapping analysis that the migration pattern of the CNCC 
in the Ednra-/- embryos is aberrant in the outflow tract. The rate of apoptosis and 
proliferation was normal in the mutant embryos. With the knowledge that the premature 
arrest of the migration of CNCC in the COFT of Ednra-/- embryos was not due to 
abnormal apoptosis or proliferation, we hypothesized that the premature arrest of cardiac 
neural crest cells migration pattern was due to improper gene expression during this 
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stage of development. We began our gene expression analysis in Ednra mutant embryos 
by performing microarray to identify genes whose expression is altered in the mutant 
embryo and performed whole mount in situ hybridization using probes for some of the 
genes identified. The genes were chosen as they were involved in cell migration, 
patterning, or had an unknown function and included Clavesin 1, Clavesin 2, Netrin G1, 
CCR1, Nppa, Islet 1, Cdc42, Zac 1, and Bmp 2. We analyzed the expression in E9.5 
murine embryos when the migratory phenotype appears and the CNCC are migrating in 
the outflow tract region. 
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3. MATERIALS AND METHODS 
Mice and Genotyping 
 The protocol for the use of animals was approved by the Institutional Animal 
Care and Use Committee at Texas A&M University Baylor College of Dentistry, and the 
animals used in these experiments were euthanized following the National Institutes of 
Health guidelines. 
 Ednra mutant embryos were generated and genotyping was done as described 
previously (Clouthier et al., 1998). 
 
RNA Extraction 
 RNA was extracted from both embryonic and adult murine tissue using the 
Trizol method following the manufacturer's instructions (Invitrogen). 
 
Reverse Transcripion 
 We performed reverse transcription using 5-10 g of DNase-treated RNA, 
combined with 5 l of Hexanucleotide mix and water to reach a final volume of 42 l. 
This mixture was placed in a 65C water bath for 5 minutes and then cooled at room 
temperature for 10 minutes. To this mixture 10 l Buffer, 1 l RNase inhibitor, 5 l 
dNTP and 2 l mmLV Reverse Transcriptase was added and incubated for 1 hour at 
37C. 
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 Polymerase Chain Reaction 
 Polymerase Chain Reaction (PCR) was done using primers specific for Clavesin 
1, Clavesin 2, Netrin G1, CCR1, Nppa, Cdc42, Zac 1, Rgs 5, and Bmp 2. PCR was done 
again using the initial PCR products as a template and their respective T7 tagged 
primers. Resulting PCR products were used as a template with the T7 RNA polymerase 
enzyme to generate the riboprobes for use in whole mount in situ hybridization. A 1% 
agarose gel was used for analyzing PCR products by gel electrophoresis. 
 
Whole Mount In Situ Hybridization 
 Whole mount in situ hybridization was done on E9.5 embryos and carried out 
over a four-day time period. Embryos were fixed in 4% paraformaldehyde in PBS 
overnight at 4C. Embryos were rinsed with PBT (PBS + 0.1% Tween 20) and placed in 
100% methanol then bleached with 6% hydrogen peroxide for 5 hours followed by 
rinsing in 100% methanol and stored in 100% methanol at -20C until ready to proceed. 
Embryos were rinsed in a series of 5 minute methanol/PBT washes (75%, 50%, 25%, 
PBT only) and treated with approximately 10 g/ml proteinase K in 2 ml PBT for 7 
minutes. Embryos were washed twice for 5 minutes with 2 mg/ml glycine in PBT 
followed by three 5 minute washes in PBT. Embryos were refixed in fresh 4% 
paraformaldehyde/ 0.2% glutaraldehyde in PBT for 20 minutes and rinsed twice with 
PBT. Hybridization involved transferring the embryos to a 1.5 ml eppendorf tube and 
rinsing with 0.5 ml of hybridization buffer (5X SSC pH 5, 1% SDS, 50 g/ml yeast 
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tRNA, 50 g/ml heparin, 50% formamide), replacing the hybridization buffer with 1ml 
fresh hybridization buffer after the embryos sunk to the bottom of the tube. Embryos 
were prehybridized at 65C for 1 hour with gentle shaking followed by replacing the 
buffer with 400 l fresh hybridization buffer with 5 l probe and were incubated 
overnight at 65C with gentle shaking. Washes were performed the following day with 
two 30 minute washes at 65C in wash solution 1 (5X SSC, 1% SDS, 50% formamide) 
followed by a 10 minute wash at 65C in a 1:1 mix of wash solutions 1 and 2. The 
embryos were then washed three times for 5 minutes at room temperature in wash 
solution 2 (0.5 M NaCl, 10mM Tris-HCl pH 7.5, 0.1% tween 20) followed by one wash 
for 1 hour at 37C with 100 g/ml RNase A in wash solution 2. Embryos were washed 
once for 5 minutes at room temperature in wash solution 2, twice for 30 minutes at 65C 
with wash solution 3 (2X SSC, 0.1% tween 20, 50% formamide) and three times with 
TBST (Tris-buffered saline with 0.1% tween 20). Embryos were pre-blocked with 1 ml 
of 10% sheep serum in TBST for 1.5 hours which was then removed and replaced with 
the preabsorbed antibody (3 mg embryo powder to 0.5 ml TBST was heated at 70C for 
30 minutes and cooled on ice. 5 l of sheep serum and 1 l of anti-digoxigenin antibody 
coupled to alkaline phosphatase was added and shaken for 1 hour at 4C. Solution was 
centrifuged for 10 minutes at 4C and the supernatant was recovered and diluted with 
1% sheep serum in TBST to a 1:2000 concentration). Embryos were incubated with the 
preabsorbed antibody overnight at 4C with gentle shaking. Embryos were rinsed three 
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times for 10 minutes with TBST followed by transfer to a 15 ml round bottom tube and 
washed five times for 1 hour each at 4C with 10 ml of TBST followed by an overnight 
wash to reduce background. Embryos were washed twice the following morning in fresh 
NTMT (100 mM NaCl, 100 mM Tris-HCl pH 9.5, 50mM MgCl2, 0.1% Tween 20) 
containing 2mM levamisole for 10 minutes and transferred to a glass scintillation vial 
where they were incubated in 2 ml NTMT (containing 2 mM levamisole with 4.5 l 
NBT and 3.5 l BCIP per ml) in the dark. Embryos were checked every five minutes and 
when color developed, the embryos were rinsed 5 times with PBT and observed under 
the stereoscope as described previously.  
 
Immunohistochemistry 
 For the immunohistological assays, E9.5 wildtype and Ednra-/- embryos were 
fixed in 4% paraformaldehyde/PBS, dehydrated in graded ethanols, embedded in 
paraffin and sectioned at 8 m along the sagittal plane. After deparaffination and 
rehydration, the sections were treated either with citric acid or Vector Labs high pH 
Antigen Unmasking solution at 90C for 20 minutes to unmask the antigens. After 
blocking, the sections were incubated with the recommended concentration of primary 
antibodies diluted in PBS overnight at 4C. The next day, the sections were rinsed and 
incubated with Alexa fluor-coupled secondary antibodies (Invitrogen). The rinsed slides 
were mounted with Slowfade Gold containing DAPI (Invitrogen) to counterstain the 
nuclei and then examined by fluorescence microscopy with a Leica TCS SP5 II confocal 
16 
microscope fitted for digital imaging. The antibody for Cdc42 was obtained from 
Abcam, the active RacGTP antibody was purchased from NewEast Biosciences, and 
Epitomics was the provider of the Rho and Rho GEF antibodies. 
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4. RESULTS 
 Migration of the cardiac neural crest cells prematurely arrested in the outflow 
tract of Ednra mutant embryos. The phenotype is not due to abnormal apoptosis or cell 
proliferation. We hypothesized that the aberrant migration pattern of the CNCC  and 
improper rearrangement of the PAA in Ednra-/- is caused by altered gene expression. In 
an attempt to choose the genes most relevant for our study, we performed microarray 
analysis on E9.5 wildtype and Ednra mutant embryos. The heart and pharyngeal arches 
3 and 4 were dissected, and RNA was isolated from the area for microarray analysis. 
From the genes shown to be expressed in the cardiac region at this stage, we selected 
several genes known to be involved in migration, patterning, cardiac development or 
with unknown function that we thought would be helpful to identify and potentially 
elucidate their role in the endothelin signaling pathway during cardiac development. 
 In order to analyze the genes involved and identify if the selected genes 
displayed altered expression in Ednra mutant embryos, whole mount in situ 
hybridization was done on E9.5 embryos using Clavesin 1, Clavesin 2, Netrin G1, 
CCR1, Nppa, Cdc42, Zac 1, Islet 1 and Bmp 2. All were analyzed using a stereoscope to 
examine the differences in the wild type and Ednra mutant embryos. 
 
Bmp2 
 Bone morphogenetic protein 2 plays a role in the development of bone and 
cartilage and also cardiac cell differentiation (Ghosh-Choudhury et al. 2003). Bmp2 is 
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also involved in the process of epithelial to mesenchymal transition of cells, and 
activation of key regulatory myocardial genes are dependent on the bone morphogenic 
protein signaling family, which includes Bmp2 (Ghosh-Choudhury et al. 2003; 
Buckingham, Meilhac, Zaffran, 2005). This factor is important in early embryogenesis 
for mesoderm formation and cardiac development. Knockout of Bmp2 results in 
embryonic lethality while Bmp2 deficient mice display cardiac defects (Wang et al. 
2014). We observed that the Ednra -/- had increased Bmp2 expression in the ventricle 
and COFT when compared to the wildtype (Figure 5). These results match a previous 
publication indicating that endothelin signaling was needed to repress cardiac Bmp2 
expression during cardiac development (Asai et al 2010).  
 
Zac1 
 Zac1 is a zinc finger transcription factor involved in regulating apoptosis and cell 
cycle arrest and is known to play a role in cardiovascular development. Knockout of 
Zac1 results in cardiovascular defects including atrial septal defects as well as 
ventricular septal defects (Yuasa et al., 2010; Varrault et al. 2006). Zac1 is expressed in 
the heart during its cardiac crescent stage and is important for morphogenesis (Yuasa et 
al, 2010). The Zac1 knockout also presents with fetal growth restriction (Varrault et al. 
2006). Zac1 has also been identified by Yuasa et al. as a potential activator of Nppa gene 
expression (Yuasa et al. 2010). The Ednra mutant embryos displayed increased 
expression of Zac1 in the bulbus cordis and  left ventricle. Expression also appeared to 
be slightly increased in the cardiac outflow tract of the Ednra mutant. The Ednra mutant 
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also presents with higher Zac1 expression in the crest cells around the arch arteries when 
compared to the wildtype embryo (Figure 5).   
 
CCR1 
 Chemokine receptor 1 (CCR1), also designated CD191 (cluster of differentiation 
191), is important for wound healing, recruitment of immune cells as well as neutrophil 
trafficking and proliferation (Khan et al. 2001). CCR1 is involved in embryologic 
development and angiogenesis (Pease and Horuk 2009; Mortier et al. 2008). In the E9.5 
Ednra mutant, CCR1 expression was lower in the bulbus cordis, future left ventricle, and 
in crest cells mainly around where the cranial nerves develop. Upon dissection, it also 
appeared that the Ednra-/- presents with lower CCR1 expression in the cardiac outflow 
tract when compared to the wildtype (Figure 5). 
 
Nppa 
 Natriuretic peptide A (Nppa), also called atrial natriuretic peptide (ANP), is an 
important modulator of cardiac hypertrophy and knockouts suffer from exaggerated 
cardiac enlargement, left ventricular hypertrophy and increased blood pressure (Mori et 
al. 2004). Because Nppa is associated with maturation of the left ventricle, we expected 
to see expression changes during cardiac development (Buckingham, Meilhac, Zaffran, 
2005). Figure 5 shows expression of Nppa during this stage of development and the 
Ednra mutant presents with weaker Nppa expression in the cardiac outflow tract when 
compared to the wildtype but ventricular expression did not appear to be altered. 
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 Netrin G1 
 Netrin G1, also called laminet-1, is in the Netrin family and normally found in 
the nervous system, pancreas, and cardiac muscle tissue. The Netrin family is known to 
guide cell migration and the primary role of Netrin G1 is in axonal guidance. Knockout 
of Netrin G1 results in selective mislocation of receptors but not axonal mistargeting 
(Barallobre et al. 2005; Nishimura-Akiyoshi et al. 2007). Netrin G1 is associated with 
neural crest differentiation as well as providing signals for synapse development 
(Matsukawa et al., 2014; Cavard et al. 2009). The Ednra -/- displayed a stronger 
expression of Netrin G1 in the cardiac outflow tract and ventricle than the wild type at 
E9.5 (Figure 5). 
 
Clavesin 1  
 Clavesin 1 (CLVS1) is sometimes referred to as retinaldehyde binding protein 1 
and, while its normal function is not fully understood, it is probably a nucleolar protein 
or a vesicle protein. In 2009, Katoh and colleagues performed specific knockdowns of 
the clathrin vesicle associated Sec14 protein in neurons and discovered it does play a 
role in neuronal function, however, Clavesin 1 function is still greatly unknown (Katoh 
et al. 2009). Analysis of the gene expression in E9.5 embryos showed no significant 
difference in Clavesin 1 between the Ednra -/- and the wildtype mice in neural crest cells 
(Figure 6). E9.5 wildtype and Ednra -/- have grossly similar Clavesin 1 gene expression; 
however, upon dissection of the heart, it became apparent that the expression in the 
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bulbus cordis, the future right ventricle of the Ednra mutant, was significantly weaker 
than in the wildtype (Figure 6). The ventricles and arches in the wildtype and Ednra 
mutant hearts did not appear to have any significant differences in Clavesin 1 expression 
(Figure 6). Analysis of the anatomical expression of Clavesin 1 in E10.5 embryos shows 
obvious expression in what appears to be all crest cells in the wild type whereas the 
Ednra mutant shows almost complete lack of expression throughout the entire embryo. 
The E10.5 Ednra mutant did display nominal expression on the limbs, but was otherwise 
lacking in Clavesin 1 gene expression. 
 
Clavesin 2  
 Clavesin 2 is also a clathrin vesicle associated Sec14 protein whose function is 
largely unknown, however, it is believed to be important in normal morphology of 
endosomes and lysosomes in neurons (Katoh et al. 2009). Clavesin 2 was selected due to 
its similarity to Clavesin 1. Since the normal function of this gene is unclear, we were 
unsure what the results of our analysis may show. Upon observation of the wild type and 
Ednra mutant embryos, no significantly apparent differences in Clavesin 2 gene 
expression were noted between the two genotypes (Figure 6). 
 
Islet 1 
 Islet 1 is responsible for encoding the insulin gene enhancer protein ISL1. Islet 1 
known to play a role in secondary heart field development and is considered a marker for 
cardiac progenitors of the secondary heart field though it also labels cardiac neural crest 
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cells (Asai et al., 2010; Engleka et al. 2012). Mutations in the Islet 1 gene result in 
complete lack of the outflow tract (Buckingham, Meilhac, Zaffran, 2005). We did see 
the expression of Islet 1, however, we did not observe any difference in Islet 1 gene 
expression between the wildtype and Ednra-/- embryos (Results not shown). This 
indicates the migration of the second heart field myocytes is occurring normally in the 
absence of Endothelin receptor A, and the defects are due to migration of the CNCC 
rather than issues with the second heart field myocytes.   
MF20 
To confirm that the migration defect is affecting the CNCC and not the second 
heart field myocytes, we looked for the presence of myocytes with the MF20 antibody at 
E10.5. The analysis confirmed what we saw initially with the expression of Islet 1 and 
we saw no difference in expression in the wildtype and mutant embryos (results not 
shown). 
Rho Family of GTPases 
Upon completing our anatomical analysis of gene expression in Ednra mutant 
embryos, we have identified a number of genes that display altered expression in mutant 
embryos that could potentially explain the heart defects seen in these mutants. However, 
with identifying the anatomical expression of these genes, we could not explain the 
CNCC migration phenotype in the cardiac outflow tract. We decided to analyze the Rho 
family of small GTPases known for their role in cell migration. The Rho family of 
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GTPases are involved in the regulation of many aspects of intracellular actin dynamics 
and play a role in organelle development, cytoskeletal dynamics and, notably, cellular 
movement.  
 We examined E9.5 wild type and Ednra mutant embryos to determine the 
presence of small GTP-binding proteins Rho and Rho GEF, Rac1 and 2, and Cdc42. We 
saw no difference between the wildtype and mutant when looking at the 
immunohistochemistry for Rho and Rho GEF (results not shown). Our analysis of the 
location of Rac GTP proteins showed no differences in the Rac GTP proteins, the 
activated form of Rac 1 and 2, in the cardiac neural crest cells (Figure 7). However, there 
appeared to be greatly increased expression of Rac GTP in the myomesium of the Ednra 
mutant (Figure 7).  
 We performed immunohistochemistry using Cdc42 and observed abundant 
localization in all cells in the wildtype with brightly visible signal in the NCC migrating 
in the COFT. In the mutant, Cdc42 activation in the NCC of the cardiac outflow tract 
was not observed but was normally present in the other tissues. Immunohistochemistry 
revealed that Cdc42 failed to localize at the migratory fronts in the CNCC in the Ednra 
mutant embryos (Figure 7). We also performed whole mount in situ hybridization to 
observe Cdc42 expression in the heart. Expression was great throughout the heart and 
we were not able to identify any differences in Cdc42 expression between the wildtype 
and the mutant due to the high level of expression in this area at this stage of 
development. 
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 With RacGTP expression abnormal in the myomesium of the mutant embryos 
and Cdc42 abnormal in the CNCC of Ednra mutants, we can conclude there are issues 
with the localizing proteins that contribute to the premature arrest of the CNCC in the 
outflow tract of these mutants. 
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 5. SUMMARY AND CONCLUSION 
 Normal Ednra function is crucial for proper development. Endothelin signaling is 
involved in neural crest cell migration, and inactivation of the gene encoding the  
Endothelin A receptor in the murine model results in characteristic defects including 
craniofacial and cardiovascular defects. The absence of Ednra signaling in cephalic NCC 
results in the transformation of the mandible into maxillae-like structures (Ruest and 
Clouthier, 2009; Ruest et al., 2004).  
 The cardiovascular defects seen in Ednra mutant embryos include persistent 
patent ductus arteriosus, coarctation of the aorta and ventricular septal defects. Ednra is 
perhaps one of the earliest mechanisms involved in neural crest cell patterning around 
E9.5 and earlier while these cells are migrating toward the arches and cardiac outflow 
tract (Ruest and Clouthier 2009). The defects seen in Ednra mutant embryos are caused 
by disrupted gene expression and further elucidation of the Ednra signaling pathway, 
along with identifying the key players involved in this signaling pathway, is essential to 
understanding this complex signaling pathway and its role in development. 
 Fate mapping analysis revealed the migratory pattern of the cardiac neural crest 
cells in the pharyngeal arches and arteries is normal in the Ednra mutant embryos and 
that these cells arrest prematurely prior to populating the cardiac outflow tract. The 
migration is aberrant upon reaching the truncus portion of the outflow tract at E9.5 in the 
E18.5 mutant embryos, the CNCC appear to normally populate the great arteries but fail 
to populate the superior portion of the heart. Ednra mutants display malformed vascular 
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structures, but these structures do contain CNCC showing that the migration of the 
CNCC occurs normally until they reach the OFT in mutant embryos.  
 Cell viability and proliferation appeared normal in E9.5 mutant embryos. Asai 
and colleagues previously stated that they did not see a difference in the proportion of 
apoptotic cells in the COFT when comparing Ednra mutants to both the wildtypes and 
heterozygotes (Asai et al. 2010). We expected to see similar results and upon our 
confirming that the premature arrest of CNCC was not due to increased apoptosis or 
decreased proliferation, it became evident that the arrest of the cardiac neural crest cells 
during their population of the outflow tract is likely due to the failure of the activation of 
expression of specific genes necessary for the migration of these CNCC.  
 The over expression of Netrin G1 appears to occur only in the COFT of the 
Ednra mutant embryos, while the over expression of Zac1 occurs in the mutant left 
ventricle and bulbus cordis as well as in crest cells around the arches.  
 The expression of Nppa was weaker in the cardiac outflow tract of Ednra mutant 
embryos, and CCR1 was also weaker in the outflow tract, bulbus cordis and in the crest 
cells around where the cranial nerves develop in Ednra mutant embryos. 
 Clavesin 1 gene expression in E9.5 embryos show grossly similar expression 
between the wildtype and mutant but upon dissection, it was apparent the expression in 
the bulbus cordis of the Ednra mutant was significantly weaker than that of the wildtype. 
We chose to further analyze the expression of this gene at E10.5 and the Clavesin 1 
expression was prevalent in what appear to be all crest cells in the wildtype, with near 
complete lack of expression with nominal expression on the limbs in the Ednra mutant. 
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These findings are significant in that we have identified that Clavesin 1 gene expression 
is regulated early on by the Ednra signaling pathway and is essential in the coordination 
of the migration of cardiac neural crest cells in the outflow tract. While the function of 
Clavesin 1 is not yet understood, one possible function for Clavesin 1 is as a 
retinaldehyde binding protein. The neural crest cells populating the conotruncal ridges 
appear to be affected by the knockout of the retinaldehyde receptors (Ghyselinek et al. 
1998). The link between the knockout of the Endothelin receptor A and the 
retinaldehyde receptors leads us to presume that they are potentially involved in the 
same pathway. Coupling the results we have shown with the change in Clavesin 1 gene 
expression in Ednra mutants and the belief that Clavesin 1 is a retinaldehyde binding 
protein, we can presumably link the activities of retnoic acid and the Ednra pathway. 
 Previous studies have shown at E8.5 that there is no obvious change of Bmp2 
expression in Ednra mutant embryos and at E9.5 the expression is increased (Asai et al., 
2010). We saw increased expression in the left ventricle as well as in the pharyngeal 
arch arteries and the aortic sac. These results are consistent with previous findings of 
increased Bmp2 gene expression in the heart of Ednra-/- embryos. BMP signaling has 
been known to play a role in second heart field development. Prall et al. showed, using a 
Nkx2.5 null mouse, that the BMP signaling pathway is important in holding the second 
heart field in a proliferative state as the first heart field differentiates (Prall et al. 2007). 
This process occurs with Nkx2.5 normally acting as a Smad1 inhibitor which results in 
downregulation of Bmp2 signaling and holds the second heart field progenitor cells 
inactive during the development of the initial heart tube (Prall et al. 2007). Because the 
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inhibition of Bmp2 signaling is involved in holding the second heart field in a 
proliferative state, we expected the signaling to be active during the differentiation of the 
second heart field progenitors. The study done by Prall et al. displayed this clearly by 
examining a Nkx2.5 null mouse in which the expression of BMP was not inhibited, thus 
there were no progenitors to add during second heart field differentiation as they had 
already differentiated with the first heart field (Prall et al., 2007). The increased Bmp2 
expression in the Ednra mutant embryos in the left ventricle, pharyngeal arch arteries, 
and aortic sac, suggest that knockout of the Ednra pathway results in uncontrolled Bmp2 
expression, however, the consequences of increased expression are unknown. 
 Islet 1 did not show any difference in expression between the Ednra mutant and 
the wildtype. This result was expected as the expression of Islet 1 is seen in nearly the 
entire progenitor population of heart cells and the expression is expected to diminish 
during myocardial differentiation (Sun et al., 2007). Islet 1 has previously been 
identified as a heart field marker, and lineage analysis has traced these cells to the right 
ventricle, outflow tract, atria and portions of the left ventricle (Yuan and Schoenwolf, 
2000; Cai et al. 2003). Knockout of Islet 1 supports these lineage tracings as the 
knockout lacks these regions (Cai et al. 2003). The crest cells, on the other hand, are 
involved in both the formation of the COFT and rearrangement of the pharyngeal arch 
arteries. Because we did not see any difference in gene expression of Islet 1 in the 
Ednra-/- we can conclude that the migration of the second heart field myocytes is 
occurring normally and that the migratory phenotype solely affects the cardiac neural 
crest cells. 
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 To confirm this finding, we looked for the presence of myocytes with the MF20 
antibody at E10.5 and saw no difference between the wildtype and mutant at this stage. 
This confirms that the migratory phenotype affects the cardiac neural crest cells and not 
the second heart field myocytes. 
 After identifying several genes and confirming our hypothesis that there is 
altered gene expression in Ednra mutant embryos, we decided to look a step further and 
try to answer why these CNCC stop their migration in the COFT of Ednra mutants. To 
answer this question, we looked into the presence of small GTPase localizing factors. 
One small GTPase involved in the regulation of cellular activities, including cell 
migration as well as establishing cell polarity, is Cdc42 which cycles between GDP-
bound and GTP-bound switching between the inactive and active state (Erickson and 
Cerione, 2001; Etienne-Manneville and Hall, 2002; Cerione, 2004; Etienne-Manneville, 
2004; Heasman and Ridley, 2008; Raftopoulou and Hall, 2004). Cdc42 is in the Rho 
family and conditional knockout of Cdc42 in crest cells has shown to result in 
craniofacial and cardiovascular defects similar to the Ednra knockouts including 
persistent truncus arteriosus, hypoplastic pulmonary trunk, outflow tract defects and 
abnormal aortic arch artery patterning (Liu et al. 2013).  
 We analyzed the location of Rac 1 and 2 as well as Rho GCF and no differences 
were observed in the Rac GTP proteins or the Rho GCF in the CNCC, however, the Rac 
GTP proteins appeared to be increased in the myomesium of the Ednra mutant embryos 
likely indicating an issue with the signaling factors involved in this process. Our data 
also revealed that Cdc42 fails to localize properly in the migratory fronts of the CNCC 
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of mutant embryos. We can assume that the migratory defect seen in the Ednra mutant 
embryos is related to the disruption of Cdc42 activity in the CNCC migrating in the 
COFT and is also related to the improper RacGTP activity in the myomesium. Our data 
shows that Cdc42 activation appears to be in CNCC migrating in the COFT but not in 
the CNCC within the pharyngeal arches suggesting an important function for the protein 
in CNCC migration along the COFT. Our data also reveal that Cdc42 activation via 
Ednra signaling occurs early, and these results support the idea of the function of Cdc42 
as a downstream effector of Ednra signaling in the CNCC migrating in the COFT. 
Improper rearrangement of the pharyngeal arch arteries, as seen in the Ednra knockout 
as well as noted by Liu and colleagues in their Cdc42 conditional knockout, suggests 
that Cdc42 may also participate in the patterning and remodeling of the arteries.  
 While we are continuing to elucidate the complex Ednra pathway in hopes of one 
day preventing the high prevalence of cardiovascular defects, much research still needs 
to be done in this area. In the future, we hope to further identify genes involved in this 
pathway, as well as identify downstream targets of these genes. While we have identified 
several genes that display altered expression and have also shown a link between Cdc42 
and the Ednra pathway, we hope to investigate the migration pattern further by perhaps 
performing laser capture in the future for microarray and analysis of more localized gene 
expression to further identify why the CNCC stop migrating when they reach the OFT.  
 In conclusion, loss of the Endothelin receptor A signaling results in severe 
cardiovascular defects. However, these defects result mostly from improper patterning of 
cardiac neural crest cells during pharyngeal arch artery rearrangement. Cardiac defects 
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result from small gene expression changes in the developing heart and the Endothelin 
dependent patterning genes regulate the rearrangement of the pharyngeal arch arteries. 
Migratory defects of CNCC do not affect myocyte development from the secondary 
heart field. Also, it appears that there may be two subpopulations of CNCC : one 
independent and one dependent on the Endothelin receptor A signaling pathway for their 
migration. Finally, in the cardiac outflow tract neural crest cells, Endothelin receptor A 
signaling involves Cdc42 activity. 
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APPENDIX A 
FIGURES 
Figure 1 
Fig. 1. Analysis of cardiac neural crest cell migration in E9.5 Ednra-/- embryos. A, B. 
Lateral views of whole-stained embryos carrying the R26R and Wnt1-Cre alleles 
revealing the location of CNCC, stained in blue, in the pharyngeal arches 1 and 2 and 
COFT (oft) in control and Ednra- /- littermates. C, D. Enlarged views of the same 
embryos. The black arrowheads in C indicate the location of the CNCC migration front 
in the COFT. The same location was reported in the mutant embryo in D but the actual 
CNC migration front is indicated by the red arrowheads in this embryo. E-H. Sagittal 
sections from the whole-stained embryos and counterstained with eosin. The black 
arrowheads indicate the location of the CNCC in the wild type COFT and the relative 
position in the mutant embryo (E and F) while their actual location in the Ednra-/- 
embryo is indicated by the red arrowhead. CNCC are normally present in the pharyngeal 
arches and around the pharyngeal arch arteries (aa) 2 and 3 in the mutant embryo. h, 
heart. 
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Figure 2 
 
 
Fig. 2. Analysis of CNCC distribution in whole-stained E10.5 Ednra-/- embryos. A, B. 
Lateral views of whole-stained embryos. The black arrowheads indicate the location or 
relative location of wild type CNCC and the red arrowhead indicates the actual location 
of the CNCC in the mutant embryo. C-F. Sagittal sections, counterstained with eosin, 
through the COFT (oft) and pharyngeal arch arteries (aa) 3 and 4. 1, mandibular arch; 2 
pharyngeal arch 2; a, atria; h, heart. 
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Figure 3 
 
Fig. 3. Analysis of CNCC distribution in whole-stained E18.5 Ednra-/- hearts. Sections 
were counterstained with eosin. The black arrow in A indicates the location of the 
CNCC in the wild type (wt) heart and the equivalent location in the mutant (-/-) heart in 
C. The red arrowhead in C points to the location where the right subclavian artery (rsc) 
is missing. The black arrowhead on the section in B points to the presence of CNCC at 
the base of the ascending aorta (aao) but their absence in D in the mutant heart. The 
yellow arrow in D indicates the presence of CNCC in the patent ductus arteriosus at the 
connection site with the aorta (red arrow). ao, aorta; lcc, left common carotid; po, 
pulmonary outflow; rcc, right common carotid. 
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Figure 4 
 
 
 
 
 
 
Fig. 4. Analysis of CNCC proliferation and survival in E9.5 and E10.5 Ednra-/- 
embryos. A. Total CNCC numbers or percentages of proliferating and apoptotic cells in 
the COFT of E9.5 wild type (WT) and Ednra-/- embryos. ***, p<0.005 
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Figure 5 
 
 
Fig. 5. Analysis of gene expression in E9.5 Ednra mutant embryos. Bmp2: the mutant 
presented with increased expression in the ventricle and the outflow tract. Zac1: the 
mutant presented with increased expression in the bulbus cordis and arch arteries. Ccr1: 
there was a much smaller and deformed mutant heart which displayed decreased 
expression in the bulbus cordis, the future right ventricle, and the outflow tract. Nppa: 
whole embryo shows decreased expression in the outflow tract area of the mutant. Netrin 
G1: the mutant presents with increased expression in the outflow tract and ventricle. 
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Analysis of gene expression in E9.5 and E10.5 embryos. Clavesin 1: top box 
shows the whole embryo with a slight decrease in expression in the cardiovascular 
region. The second box shows the dissected heart and arrows indicate the decrease in 
expression in the mutant bulbus cordis. Clavesin 2: whole embryos show no difference 
in expression at E10.5. Clavesin 1: E10.5 whole embryos reveal expression in what 
appears to be all crest cells in the wildtype with almost complete lack of expression in 
the mutant with nominal expression in the limbs. 
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Figure 7 
 
 
Fig. 7. Cdc42 fails to localize properly in the CNCC of Ednra-/- embryos. Sagittal 
sections through the cardiac region of E9.5 wild type (WT) and Ednra-/- embryos were 
counterstained with DAPI to reveal the nuclei. We examine the presence and localization 
of the small GTP binding proteins Cdc42 and Rac1 and 2 (activated form, Rac GTP) in 
the CNCC (red arrows in the enlarged view from preceding photograph) migrating in the 
outflow tract (oft). No differences were observed for the localization of the Rac GTP 
proteins. However, in the mutant embryos, Cdc42 fails to localize at the edges of 
migrating CNCC, as revealed in the enlarged merged images. The enlarged area is 
framed by a red box. 1, pharyngeal (mandibular) arch 1; e, endomysium; m, 
myomysium; v, ventricle. 
